Results 151 to 160 of about 2,190 (195)

Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate

Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate
openaire  

Some of the next articles are maybe not open access.

Related searches:

Side-Effect Profile of Brimonidine Tartrate in Children

Ophthalmology, 2005
To investigate brimonidine-related side effects and the efficacy of brimonidine in lowering intraocular pressure (IOP) in children with primary infantile and secondary glaucoma.Single-center, prospective, interventional, noncomparative case series.Eighty-three children (mean age, 7.84 years) met the inclusion criteria.Medical records were reviewed to ...
Sami, Al-Shahwan, Abdullah A, Al-Torbak, Shahira, Turkmani, Mamdouh, Al-Omran, Ibrahim, Al-Jadaan, Deepak P, Edward   +5 more
openaire   +4 more sources

Pupillometry Study of Brimonidine Tartrate 0.2% and Apraclonidine 0.5%

The Journal of Clinical Pharmacology, 2011
This study investigated possible effects of brimonidine tartrate 0.2% and apraclonidine 0.5% on pupil diameter. Ten subjects between 20 and 40 years of age participated. A Colvard pupillometer (Oasis Medical) was used to measure pupil diameter. Baseline and serial measurements were obtained at 3 luminance levels (>6.4,
Eulogio, Besada, Kimberly, Reed, Perla, Najman, Diana, Shechtman, Patrick, Hardigan   +4 more
openaire   +4 more sources

Brimonidine Tartrate

Ophthalmology, 1997
Robert J. Derick, Alan L. Robin, T.R. Walters, Howard S. Barnebey, Neil Choplin, Joel Schuman, Elaine P. Kelley, Kuankuan Chen, Jack F. Stoecker   +8 more
openaire   +3 more sources

Brimonidine tartrate for the treatment of glaucoma

Expert Opinion on Pharmacotherapy, 2018
Brimonidine tartrate is a commonly used eyedrop for short- and long-term lowering of intraocular pressure. Its use has been popularized due to its effects on aqueous suppression and uveoscleral outflow, as well as the suggestion of neuroprotection. Although available with alternative preservative vehicles, brimonidine is associated with high rates of ...
Daniel J, Oh, Judy L, Chen, Thasarat S, Vajaranant, Mark S, Dikopf   +3 more
openaire   +2 more sources

Advances in Glaucoma Therapy: Brimonidine Tartrate

Seminars in Ophthalmology, 1997
Brimonidine, a newly approved α2-adrenoceptor agonist, is a 2-imidazoline derivative which is more highly selective for the α2-adrenoceptor than either clonidine or apraclonidine. The mechanism of action by which it lowers intraocular pressure (IOP) involves a decrease in aqueous humor production and an increase in aqueous humor outflow through the ...
David S. Greenfield, Jeffrey M. Liebmann, Robert Ritch   +2 more
openaire   +1 more source

Vitreous concentration of topically applied brimonidine tartrate 0.2%

Ophthalmology, 2001
To determine the vitreous concentration of brimonidine after topical administration of Alphagan.Prospective observational case series.Eighteen patients scheduled for elective pars plana vitrectomy.Brimonidine tartrate, 0.2%, was topically administered twice or three times daily for 4 to 14 days preoperatively in 13 patients.
A R, Kent, J D, Nussdorf, R, David, F, Tyson, D, Small, D, Fellows   +5 more
openaire   +2 more sources

Effect of Brimonidine Tartrate on Ocular Hemodynamics in Healthy Volunteers

Journal of Ocular Pharmacology and Therapeutics, 2001
While alpha2-adrenergic agonists, such as brimonidine tartrate, significantly reduce the intraocular pressure (IOP), the presence of vasoconstrictor postsynaptic alpha2 receptors on vascular smooth muscle raise the possibility that brimonidine could potentially compromise ocular blood flow.
Jonescu-Cuypers, Christian Paul, Harris, A, Ishii, Y, Kagemann, L, Gazozi, H J, Rotenstreich, Y, Chung, H S, Martin, B   +7 more
openaire   +3 more sources

Effect of Brimonidine Tartrate 0.15% on Scotopic Pupil: Controlled Trial

Journal of Ocular Pharmacology and Therapeutics, 2007
The aim of this study was to evaluate the duration of the effect of one single dose of brimonidine tartrate 0.15% on pupil diameter, under scotopic conditions, when applied topically in 1 eye of normal subjects.The eyes of 19 normal volunteers were randomized so that 1 eye had 1 drop of brimonidine tartrate 0.15% and the other received no medication ...
Gerente, Vanessa M., Biondi, Adriano C., Barbosa, Carolina P., Lottenberg, Claudio L., Paranhos, Augusto   +4 more
openaire   +3 more sources